Association between CD14-159C>T polymorphisms and the risk for alcoholic liver disease: A meta-analysis

European Journal of Gastroenterology and Hepatology

Volumn 25, Issue 10, 2013, Pages 1183-1189

  Zeng, Tao ^a   Zhang, Cui Li ^a   Han, Xiao Ying ^b   Zhao, Sheng ^c   Xie, Ke Qin ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG NORMAL UNIVERSITY   (China)

^c SINOPEC   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN;

ALCOHOL LIVER CIRRHOSIS; ALCOHOL LIVER DISEASE; ALCOHOLISM; ARTICLE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; META ANALYSIS (TOPIC); PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

ANTIGENS, CD14; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIVER DISEASES, ALCOHOLIC; PATIENT SELECTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 84883653695     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3283612ff1     Document Type: Article

References (41)

1. Frazier TH, Stocker AM, Kershner N.A., Marsano LS, McClain CJ Treatment of alcoholic liver disease. Therap Adv Gastroenterol 2011; 4:63-81.
2. Zeng T, Xie KQ Ethanol and liver: recent advances in the mechanisms of ethanol-induced hepatosteatosis. Arch Toxicol 2009; 83:1075-1081.
3. Lefkowitch JH. Morphology of alcoholic liver disease. Clin Liver Dis 2005; 9:37-53. (Pubitemid 40341945)
4. Bruha R, Dvorak K, Petrtyl J. Alcoholic liver disease. World J Hepatol 2012; 4:81-90.
5. Stickel F, Hampe J. Genetic determinants of alcoholic liver disease. Gut 2012; 61:150-159.
6. Zeng T, Guo FF, Zhang C.L., Song FY, Zhao XL, Xie KQ Roles of cytochrome P4502E1 gene polymorphisms and the risks of alcoholic liver disease: a meta-analysis. PloS One 2013; 8:e54188.
7. Marcos M, Pastor I, Chamorro A.J., Ciria-Abad S, Gonzalez-Sarmiento R, Laso FJ. Meta-analysis: glutathione-S-transferase allelic variants are associated with alcoholic liver disease. Aliment Pharmacol Ther 2011; 34:1159-1172.
8. Marcos M, Gomez-Munuera M, Pastor I., Gonzalez-Sarmiento R, Laso FJ Tumor necrosis factor polymorphisms and alcoholic liver disease: a HuGE review and meta-analysis. Am J Epidemiol 2009; 170:948-956.
9. Mandrekar P, Szabo G. Signalling pathways in alcohol-induced liver inflammation. J Hepatol 2009; 50:1258-1266.
10. Szabo G, Bala S. Alcoholic liver disease and the gut-liver axis. World J Gastroenterol 2010; 16:1321-1329.
11. Wheeler MD. Endotoxin and Kupffer cell activation in alcoholic liver disease. Alcohol Res Health 2003; 27:300-306. (Pubitemid 40685569)
12. Fukui H, Brauner B, Bode J.C., Bode C. Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay. J Hepatol 1991; 12:162-169.
13. Khoruts A, Stahnke L, McClain C.J., Logan G., Allen JI Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 1991; 13:267-276.
14. Bird GL, Sheron N, Goka A.K., Alexander GJ, Williams RS Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med 1990; 112:917-920. (Pubitemid 20193676)
15. Nanji AA, Khettry U, Sadrzadeh S.M., Yamanaka T. Severity of liver injury in experimental alcoholic liver disease. Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2. Am J Pathol 1993; 142:367-373. (Pubitemid 23057448)
16. Yin M, Wheeler MD, Kono H, Bradford B.U., Gallucci RM, Luster MI, et al Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology 1999; 117:942-952. (Pubitemid 29468238)
17. Adachi Y, Bradford BU, Gao W, Bojes H.K., Thurman RG Inactivation of Kupffer cells prevents early alcohol\induced liver injury. Hepatology 1994; 20:453-460. (Pubitemid 24233374)
18. Iimuro Y, Gallucci RM, Luster M.I., Kono H., Thurman RG Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology 1997; 26:1530-1537. (Pubitemid 27520019)
19. Wright SD, Ramos RA, Tobias P.S., Ulevitch RJ, Mathison JC CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249:1431-1433.
20. Ferrero E, Jiao D, Tsuberi B.Z., Tesio L., Rong GW, Haziot A, et al Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide. Proc Natl Acad Sci USA 1993; 90:2380-2384. (Pubitemid 23078630)
21. Haziot A, Ferrero E, Kontgen F., Hijiya N, Yamamoto S, Silver J., et al. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 1996; 4:407-414. (Pubitemid 26174055)
22. Lukkari TA, Jarvelainen HA, Oinonen T, Kettunen E., Lindros KO Short-term ethanol exposure increases the expression of Kupffer cell CD14 receptor and lipopolysaccharide binding protein in rat liver. Alcohol Alcohol 1999; 34:311-319. (Pubitemid 29295158)
23. Jarvelainen HA, Oinonen T, Lindros KO Alcohol-induced expression of the CD14 endotoxin receptor protein in rat Kupffer cells. Alcohol Clin Exp Res 1997; 21:1547-1551. (Pubitemid 27517942)
24. Ferrero E, Goyert SM Nucleotide sequence of the gene encoding the monocyte differentiation antigen, CD14. Nucleic Acids Res 1988; 16:4173.
25. Hubacek JA, Rothe G, Pit'ha J, Skodova Z, Stanek V, Poledne R, et al. C(-260)-T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 1999; 99:3218-3220. (Pubitemid 29293428)
26. Gu W, Dong H, Jiang D.P., Zhou J., Du DY, Gao JM, et al Functional significance of CD14 promoter polymorphisms and their clinical relevance in a Chinese Han population. Crit Care Med 2008; 36:2274-2280.
27. LeVan TD, Bloom JW, Bailey T.J., Karp CL, Halonen M, Martinez FD, et al A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J Immunol 2001; 167:5838-5844. (Pubitemid 33062776)
28. Nezi V, Deutsch M, Gazouli M., Alexopoulou A, Paparrigopoulos T, Liappas I.A., et al. Polymorphisms of the CD14 genes are associated with susceptibility to alcoholic liver disease in Greek patients. Alcohol Clin Exp Res 2013; 37:244-251.
29. Petrášek J, Hubáček JA, Stickel F, Sperl J, Berg T, Ruf E, et al. Do common genetic variants in endotoxin signaling pathway contribute to predisposition to alcoholic liver cirrhosis? Clin Chem Lab Med 2009; 47:398-404.
30. Von Hahn T., Halangk J, Witt H., Neumann K, Muller T, Puhl G., et al. Relevance of endotoxin receptor CD14 and TLR4 gene variants in chronic liver disease. Scand J Gastroenterol 2008; 43:584-592. (Pubitemid 351536047)
31. Meiler C, Muhlbauer M, Johann M., Hartmann A, Schnabl B, Wodarz N., et al. Different effects of a CD14 gene polymorphism on disease outcome in patients with alcoholic liver disease and chronic hepatitis C infection. World J Gastroenterol 2005; 11:6031-6037. (Pubitemid 41749222)
32. Martins A, Cortez-Pinto H, Machado M., Goncalves MS, Soren S, Marques-Vidal P, et al Are genetic polymorphisms of tumour necrosis factor alpha, interleukin-10, CD14 endotoxin receptor or manganese superoxide dismutase associated with alcoholic liver disease? Eur J Gastroenterol Hepatol 2005; 17:1099-1104. (Pubitemid 41424004)
33. Chao YC, Chu HC, Chang W.K., Huang HH, Hsieh TY CD14 promoter polymorphism in Chinese alcoholic patients with cirrhosis of liver and acute pancreatitis. World J Gastroenterol 2005; 11:6043-6048.
34. Leathart J, Day C, Daly A. No association between functional SNPs in the endotoxin receptors CD14 and TLR4 and alcoholic liver disease (ALD): is endotoxin important in the pathogenesis of ALD in humans. Hepatology 2001; 34:459A.
35. Jarvelainen HA, Orpana A, Perola M., Savolainen VT, Karhunen PJ, Lindros KO Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease. Hepatology 2001; 33:1148-1153. (Pubitemid 32378214)
36. Higgins JP, Thompson SG Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21:1539-1558. (Pubitemid 34746062)
37. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22:719-748.
38. Tobias A. Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull 1999; 47:15-17.
39. Tilg H, Moschen AR, Kaneider NC Pathways of liver injury in alcoholic liver disease. J Hepatol 2011; 55:1159-1161.
40. Yin M, Bradford BU, Wheeler M.D., Uesugi T., Froh M, Goyert SM, et al Reduced early alcohol-induced liver injury in CD14-deficient mice. J Immunol 2001; 166:4737-4742. (Pubitemid 32233762)
41. Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 2011; 141:1572-1585.